drugset / Trial / NCT00150787
Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.
RandomizedParallel-groupDouble-blind
Summary
A double-blind follow-up trial assessing the long term safety of Levetiracetam as per adverse events reporting, physical and neurological examination and vital signs
Timeline
- Start
- 2003-07
- Primary completion
- 2005-11
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levetiracetam | Other / unclassified | 1000 mg | Oral |
| Subject | Levetiracetam | Other / unclassified | 3000 mg | Oral |